Nucleotide-recognizing proteins and RNA

Nucleotide-recognizing proteins and RNA is a broad classification encompassing various molecular entities that bind to or process nucleotides (such as ATP or GTP) and nucleic acids (DNA and RNA). This group includes Pattern Recognition Receptors (PRRs) such as Toll-like receptors (TLR3, TLR7, TLR8, TLR9) and cGAS-STING components, which are essential for detecting pathogen-associated molecular patterns and initiating innate immune responses (Source: NIH, PubMed). It also covers purinergic receptors like P2X and P2Y, which mediate cellular signaling in response to extracellular nucleotides, influencing processes like platelet aggregation and neuroinflammation (Source: UniProt, British Journal of Pharmacology). Additionally, RNA-binding proteins and therapeutic RNA molecules, such as antisense oligonucleotides and siRNA, fall under this umbrella, serving as critical tools for modulating protein synthesis and gene expression (Source: Nature Reviews Drug Discovery). Given the breadth of this category, it is considered a functional grouping rather than a single therapeutic target, with roles spanning across oncology, infectious diseases, and cardiovascular health. Drugs targeting these systems range from nucleotide analog antivirals to monoclonal antibodies and oligonucleotide-based therapies.

Other names

Nucleic acid sensorsNucleotide-binding proteinsRNA-binding proteinsPurinergic signaling componentsNucleotide receptorsNucleic acid-sensing pathways

Mechanisms of action for drugs targeting members of this group include the competitive inhibition of viral polymerases by nucleotide analogs, the modulation of innate immune signaling through Toll-like receptor (TLR) agonism or antagonism, and the sequence-specific degradation or splicing modulation of target mRNA using oligonucleotide-based therapies (Source: Nature Reviews Drug Discovery, PubMed).